Evidence map›Paper›PMID 32506393›Full record

ReviewCurrent allergy and asthma reports2020

Allergy and Otitis Media in Clinical Practice.

Giorgio Ciprandi, Sara Torretta, Gian Luigi Marseglia, Amelia Licari, Elena Chiappini, Marco Benazzo, Maria Angela Tosca, Paola Marchisio

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current allergy and asthma reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Turbinate Hypertrophy, Allergic Rhinitis, and Otitis Media.Current allergy and asthma reports · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Giorgio CiprandiAllergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy. gio.cip@libero.it.ORCID 0000-0001-7016-8421
Sara TorrettaFondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy.
Gian Luigi MarsegliaPediatrics Clinic, Pediatrics Department, Policlinico San Matteo, University of Pavia, Pavia, Italy.
Amelia LicariPediatrics Clinic, Pediatrics Department, Policlinico San Matteo, University of Pavia, Pavia, Italy.
Elena ChiappiniMeyer Children's University Hospital, Department of Health Sciences, University of Florence, Florence, Italy.
Marco BenazzoDepartment of Otorhinolaryngology, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Maria Angela ToscaPediatric Allergy Center, Istituto Giannina Gaslini, Genoa, Italy.
Paola MarchisioFondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy.
University of Pavia · ITUniversity of Milan · ITCasa di Cura Villa Garda · ITIstituto Giannina Gaslini · ITMeyer Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewOtitis media (OM) is a disease with very high prevalence in infancy, substantial burden on healthcare resources, and relevant impact on the quality of life of families. The link between OM and allergy is controversial and still debated. However, a fundamental premise has to be placed before introducing this topic: there is the need to use clear and unambiguous terms. Literature abounds with misleading terms that significantly affect the methodology and consequently the outcomes. Moreover, it is essential to differentiate patients according to the OM type (i.e., acute OM, OM with effusion, and chronic suppurative OM), the allergic disease, and mainly the age. RECENT

findingsThere are some recent studies exploring this issue through different approaches, such as epidemiological, mechanistic, and therapeutic. To identify allergy as a pathogenic factor for OM could improve the management of OM patients. Vice versa, to suspect allergy in OM patients could be reasonable in selected patients. The current narrative review provides an overview of the evidence concerning the potential role of allergy in OM. As there are conflicting findings, a possible interpretation of pathophysiological events and a pragmatic approach are proposed.

Indexed as

AdolescentChildChild, PreschoolHumansHypersensitivityOtitis MediaPrevalenceQuality of LifeAcute otitis mediaAllergyInfectionsOtitis media with effusionRisk factorsType 2 inflammation

Identifiers

PMID32506393
OpenAlexW3034152944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.